Literature DB >> 14615725

Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada.

Lynda K Mikelova, Scott A Halperin, David Scheifele, Bruce Smith, Elizabeth Ford-Jones, Wendy Vaudry, Taj Jadavji, Barbara Law, Dorothy Moore.   

Abstract

OBJECTIVES: To describe the clinical course of fatal cases of pertussis and identify predictors of death at the time of presentation for medical care.
METHODS: Case-control study of 16 deaths from pertussis identified by the Immunization Monitoring Program, Active (IMPACT) surveillance network (January 1991-December 2001) matched with 32 nonfatal cases by age, date, and geography. Differences were compared by Fisher exact test and logistic regression. A multivariate model was developed using stepwise logistic regression.
RESULTS: All 16 fatal cases were < or =6 months old; 13 were <2 months old. Fatal cases were less likely to have had cough complications during pregnancy (48% vs 14%; P=.046) and more likely to have pneumonia (63% vs 16%; P=.0024) before hospital admission and more likely to have seizures, pneumonia, leukocytosis, and hypoxemia after admission (P<.001 for all comparisons). White blood cell count and pneumonia were independent predictors of fatal outcome in the multivariate model.
CONCLUSIONS: Infants too young to have begun their immunizations are at highest risk of fatal pertussis infection. Leukocytosis and pneumonia are predictors of a poor outcome; however, rapid progression of the disease may make interventions difficult.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615725     DOI: 10.1067/S0022-3476(03)00365-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  30 in total

1.  Update on pertussis and pertussis immunization.

Authors:  Jung Yun Hong
Journal:  Korean J Pediatr       Date:  2010-05-31

2.  How long can we expect pertussis protection to last after the adolescent booster dose of tetanus-diphtheria-pertussis (Tdap) vaccines?

Authors:  Nawaf Al Dajani; David Scheifele
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

3.  Pertussis mortality and public misperceptions.

Authors:  Rolando Ulloa-Gutierrez
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

Review 4.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

5.  Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.

Authors:  D MacDougall; B A Halperin; D MacKinnon-Cameron; L Li; S A McNeil; J M Langley; S A Halperin
Journal:  Hum Vaccin Immunother       Date:  2015-06-19       Impact factor: 3.452

Review 6.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 7.  Novel therapies for the treatment of pertussis disease.

Authors:  Karen M Scanlon; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

8.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

9.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Suffer the Infants: A Severe Case of Pertussis in Oregon, 2012.

Authors:  Juventila Liko; William J Koenig; Paul R Cieslak
Journal:  Public Health Rep       Date:  2015 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.